description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGCAAAATGGACCAGTTCAAGCCATAATGCAAGTCCGTGAAGATTTCTTCCATTATAAGACAGGGATATACAGACATGTTACCAGCACAAATAAAGAATCAGAAAAATATCGAAAGCTTCAGACACATGCAGTCAAACTCACTGGATGGGGCACACTGAGAGGAGCACAAGGGCAGAAAGAAAAATTTTGGATTGCTGCCAATTCCTGGGGAAAGTCATGGGGAGAGAATGGCTATTTCAGGATTCTTCGAGGAGTAAATGAGTCCGACATTGAAAAGTTGATTATCGCAGCTTGGGGCCAACTGACGAGTTCTGATGAACCATAACATATCATTAAATTTCCATAAGGTCATGCCTTTAAGTAACCCCCTAAATTGAAGTTTAGCAATATGACATTCTTGGTGACAGTGG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... TINAG(27283)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Meng-Hui Zhang et al.
Cancer biomarkers : section A of Disease markers, 23(1), 33-43 (2018-07-12)
Hepatocellular carcinoma (HCC) is a highly aggressive malignancy that has a poor prognosis. Through the literatures, TINAG significantly participated in the processes of the renal-associated diseases, but there were no studies about the roles of TINAG in the HCC development.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EHU070711-50UG | 04061828370702 |
| EHU070711-20UG | 04061828610365 |